AU2011261196B2 - Methods for treatment of nephrotic syndrome and related conditions - Google Patents

Methods for treatment of nephrotic syndrome and related conditions Download PDF

Info

Publication number
AU2011261196B2
AU2011261196B2 AU2011261196A AU2011261196A AU2011261196B2 AU 2011261196 B2 AU2011261196 B2 AU 2011261196B2 AU 2011261196 A AU2011261196 A AU 2011261196A AU 2011261196 A AU2011261196 A AU 2011261196A AU 2011261196 B2 AU2011261196 B2 AU 2011261196B2
Authority
AU
Australia
Prior art keywords
angptl4
angptl4 polypeptide
polypeptide
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011261196A
Other languages
English (en)
Other versions
AU2011261196A1 (en
Inventor
Sumant Chugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2011261196A1 publication Critical patent/AU2011261196A1/en
Application granted granted Critical
Publication of AU2011261196B2 publication Critical patent/AU2011261196B2/en
Assigned to CHUGH, Sumant S. reassignment CHUGH, Sumant S. Request for Assignment Assignors: THE UAB RESEARCH FOUNDATION
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2011261196A 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions Active AU2011261196B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35186610P 2010-06-05 2010-06-05
US61/351,866 2010-06-05
PCT/US2011/039255 WO2011153525A2 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions

Publications (2)

Publication Number Publication Date
AU2011261196A1 AU2011261196A1 (en) 2013-01-10
AU2011261196B2 true AU2011261196B2 (en) 2015-05-21

Family

ID=45067339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011261196A Active AU2011261196B2 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions

Country Status (12)

Country Link
EP (2) EP2575858B1 (enExample)
JP (1) JP5904560B2 (enExample)
KR (1) KR20130132375A (enExample)
CN (2) CN103140234B (enExample)
AU (1) AU2011261196B2 (enExample)
CA (1) CA2801579C (enExample)
DK (1) DK2575858T3 (enExample)
ES (1) ES2663096T3 (enExample)
NO (1) NO2575858T3 (enExample)
PL (1) PL2575858T3 (enExample)
PT (1) PT2575858T (enExample)
WO (1) WO2011153525A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110301103A1 (en) 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
JP2016516726A (ja) * 2013-03-15 2016-06-09 ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン ネフローゼ症候群及び関連状態の治療方法
WO2015107501A1 (en) * 2014-01-20 2015-07-23 Ghiggeri Gian Marco In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis
CN114934021B (zh) * 2022-04-21 2023-08-08 复旦大学附属儿科医院 一种Angptl3敲除的鼠永生化足细胞系及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228659A1 (en) * 1999-07-16 2003-12-11 Ballinger Dennis G. Novel angiopoietin materials and methods
WO2006014678A2 (en) * 2004-07-20 2006-02-09 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005080508A (ja) * 2003-09-04 2005-03-31 Sankyo Co Ltd 脂質代謝改善剤の試験方法
CN1980686A (zh) * 2004-04-05 2007-06-13 安斯泰来制药有限公司 抗肥胖药
EP2007899B1 (en) * 2006-03-20 2017-06-07 Celldex Therapeutics, Inc. Antibodies directed to angiopoietin-like protein 4 and uses thereof
CA2903133C (en) * 2007-05-31 2021-10-19 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine or derivatives thereof for use in treating a kidney disorder in a mammal

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228659A1 (en) * 1999-07-16 2003-12-11 Ballinger Dennis G. Novel angiopoietin materials and methods
WO2006014678A2 (en) * 2004-07-20 2006-02-09 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LEE, E et al (2009) J. Biol. Chem. 284: 13735-13745 *
YIN, W et al (2009) J. Biol. Chem. 284: 13213-13222 *

Also Published As

Publication number Publication date
JP5904560B2 (ja) 2016-04-13
CA2801579C (en) 2021-12-14
JP2013528625A (ja) 2013-07-11
PL2575858T3 (pl) 2018-08-31
CN103140234B (zh) 2016-12-21
ES2663096T3 (es) 2018-04-11
CA2801579A1 (en) 2011-12-08
HK1252916A1 (en) 2019-06-06
AU2011261196A1 (en) 2013-01-10
WO2011153525A2 (en) 2011-12-08
KR20130132375A (ko) 2013-12-04
EP3318269B1 (en) 2024-03-13
NO2575858T3 (enExample) 2018-05-19
EP2575858A4 (en) 2014-01-01
EP2575858A2 (en) 2013-04-10
CN103140234A (zh) 2013-06-05
EP3318269A1 (en) 2018-05-09
WO2011153525A9 (en) 2012-04-19
DK2575858T3 (en) 2018-03-12
EP3318269C0 (en) 2024-03-13
PT2575858T (pt) 2018-03-22
CN107412729A (zh) 2017-12-01
EP2575858B1 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
AU2011261196B2 (en) Methods for treatment of nephrotic syndrome and related conditions
CA2801770C (en) Methods of treating nephrotic syndrome
US9475850B2 (en) Methods for treatment of nephrotic syndrome and related conditions
US11866468B2 (en) Methods for treatment of nephrotic syndrome and related conditions
EP2970416B1 (en) Methods for treatment of nephrotic syndrome and related conditions
HK1252916B (en) Use of an angiopoietin-like 4 (angptl4) polypeptide in the manufacture of a medicament for the treatment of proteinuria.
HK1220213B (en) Methods for treatment of nephrotic syndrome and related conditions

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: CHUGH, SUMANT S.

Free format text: FORMER OWNER WAS: THE UAB RESEARCH FOUNDATION